Novo Nordisk rebounds as Kepler upgrades Ozempic maker at long last
Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...
Novo Nordisk upgraded to Buy from Hold at Kepler Cheuvreux
Kepler Cheuvreux upgraded Novo Nordisk (NVO) to Buy from Hold with a price target of DKK 630, down from DKK 715. The firm views the company’s ...
Mowi re-initiated with a Buy at Kepler Cheuvreux
Kepler Cheuvreux re-initiated coverage of Mowi (MHGVY) with a Buy rating and NOK 266 price target The firm believes the company’s harvest ...